PDCD1 and atherosclerosis: Another study evaluated the effect of co-treatment with PD-1 and TIM-3 inhibitor and it was found that cytokines which exert anti-atherogeneic effect were reduced but TNF-α and IFN-γ levels were amplified resulting in advancement of atherosclerosis (237).